Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Thermo Fisher ( (TMO) ) just unveiled an update.
On February 19, 2025, Thermo Fisher Scientific Inc. expanded its board of directors to include Karen S. Lynch, a seasoned healthcare executive with extensive experience at companies like CVS Health, Aetna, and Cigna. This strategic appointment is expected to bolster the company’s industry positioning, particularly in healthcare solutions, as Lynch brings a wealth of knowledge and leadership experience that could influence Thermo Fisher’s operations and impact its stakeholders positively.
More about Thermo Fisher
Thermo Fisher Scientific Inc. operates in the scientific and healthcare industry, providing products and services that support laboratory research and development. The company is known for its focus on innovation and technological advancements in the field of life sciences.
YTD Price Performance: 0.10%
Average Trading Volume: 2,041,248
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $200.1B
For detailed information about TMO stock, go to TipRanks’ Stock Analysis page.